Scribe Therapeutics Inc. SCTX
12.07 USD -1.15 (-8.70%)
Regular-session close
12.07 0.00 0.00%
After hours · Nov 20, 4:26 PM ET
12.00 Day range 13.40
12.00 52-week range 39.60
- YTD
- -36.37%
- 1 year
- -36.37%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 51.17M | 27.41M | |
| 51.17M | 27.41M | |
| -26.07M | -42.83M | |
| -21.81M | -47.79M | |
| -1.52 | -3.37 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 13.47M | 13.28M | |
| 78.22M | 127.97M | |
| 101.28M | 133.47M | |
| 41.43M | 41.68M | |
| -143.42M | -125.86M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -45.21M | -45.23M | |
| 45.27M | 13.01M | |
| 142.00K | -222.00K | |
| -1.27M | -1.35M | |
| 194.00K | -32.44M |
